Skip to main content
Erschienen in: PharmacoEconomics 18/2004

01.12.2004 | Original Research Article

Discrete choice experiment to derive willingness to pay for methyl aminolevulinate photodynamic therapy versus simple excision surgery in basal cell carcinoma

verfasst von: Adele Weston, Dr Patrick FitzGerald

Erschienen in: PharmacoEconomics | Ausgabe 18/2004

Einloggen, um Zugang zu erhalten

Abstract

Objectives: This study aimed to determine willingness to pay (WTP) and preference for methyl aminolevulinate (MAL) photodynamic therapy compared with simple surgical excision for basal cell carcinoma (BCC). The relative preferences for individual features of the therapy were also determined.
Design: A discrete-choice experiment was conducted to ascertain WTP and relative preferences for treatment of BCC among the general population.
Subjects and methods: Sixty members of the general public (34 men, 26 women; mean age 50 ± 13 years) completed a written questionnaire. Participants indicated their preference between 12 pairs of scenarios representing BCC treatment. The paired scenarios comprised a fixed scenario representing current standard treatment (simple surgical excision) and an alternative scenario. Scenarios comprised five attributes: lesion response rate, risk of scarring, treatment description, possibility of infection and cost. Clinical attributes and levels were derived from clinical trial data. WTP values were in Australian dollars ($A, year 2001 values) and the study was conducted from the societal perspective.
Results: The probability that MAL photodynamic therapy with topical anaesthesia would be accepted in preference to current treatment was 0.879, if there was no cost differential. Total incremental WTP was $A940 for MAL photodynamic therapy. The primary driver of total WTP was reduced risk of scarring, which contributed $A554, but treatment description and infection rate also made significant positive contributions. By contrast, the marginally higher lesion response rate with simple surgical excision (93%) compared with MAL photodynamic therapy (84%) did not significantly reduce WTP. Demographic factors had negligible influence upon the results. Sensitivity analyses indicated that incremental WTP for MAL photodynamic therapy was strongly influenced by the presence of anaesthetic.
Conclusion: There appears to be a sizeable incremental WTP for MAL photodynamic therapy with anaesthetic for the treatment of BCC relative to simple surgical excision, and this is largely driven by better cosmetic outcomes.
Fußnoten
1
Trade names are used for identification purposes only and do not imply endorsement.
 
Literatur
1.
Zurück zum Zitat Raasch B. Suspicious skin lesions and their management. Aust Fam Physician 1999; 28: 466–71PubMed Raasch B. Suspicious skin lesions and their management. Aust Fam Physician 1999; 28: 466–71PubMed
2.
Zurück zum Zitat Medicare Benefits Schedule item statistics. 1999–2000 [online]. Available from URL: http://www.hic.gov.au/statistics/ dyn mbs/forms/mbs tab4.shtml [Accessed 2001] Medicare Benefits Schedule item statistics. 1999–2000 [online]. Available from URL: http://​www.​hic.​gov.​au/​statistics/​ dyn mbs/forms/mbs tab4.shtml [Accessed 2001]
3.
Zurück zum Zitat Rhodes LE, De Rie M, Enström Y, et al. Photodynamic therapy using topical methyl aminolevulinate vs surgery for treatment of primary nodular basal cell carcinoma: results of a randomized prospective trial. Archives of Dermatology 2004; 140 (1): 17–23PubMedCrossRef Rhodes LE, De Rie M, Enström Y, et al. Photodynamic therapy using topical methyl aminolevulinate vs surgery for treatment of primary nodular basal cell carcinoma: results of a randomized prospective trial. Archives of Dermatology 2004; 140 (1): 17–23PubMedCrossRef
4.
Zurück zum Zitat Metvix® (methylaminolevulinate photodynamic therapy) product information. Oslo: PhotoCure ASA, 2001 Metvix® (methylaminolevulinate photodynamic therapy) product information. Oslo: PhotoCure ASA, 2001
5.
Zurück zum Zitat Myers RH, Montgomery DC. Response surface methodology: process and product optimization using designed experiments. New York: Wiley, 1995 Myers RH, Montgomery DC. Response surface methodology: process and product optimization using designed experiments. New York: Wiley, 1995
6.
Zurück zum Zitat Kuhfeld WF, Tobias RD, Garratt M. Efficient experimental designs with marketing research applications. J Mark Res 1994; 31: 545–57CrossRef Kuhfeld WF, Tobias RD, Garratt M. Efficient experimental designs with marketing research applications. J Mark Res 1994; 31: 545–57CrossRef
7.
Zurück zum Zitat Jan S, Mooney G, Ryan M, et al. The use of conjoint analysis to elicit community preferences in public health research: a case study of hospital services in South Australia. Aust N Z J Public Health 2000; 24: 64–70PubMedCrossRef Jan S, Mooney G, Ryan M, et al. The use of conjoint analysis to elicit community preferences in public health research: a case study of hospital services in South Australia. Aust N Z J Public Health 2000; 24: 64–70PubMedCrossRef
8.
Zurück zum Zitat Ryan M, Farrar S. Using conjoint analysis to elicit preferences for health care. BMJ 2000; 320: 1530–2PubMedCrossRef Ryan M, Farrar S. Using conjoint analysis to elicit preferences for health care. BMJ 2000; 320: 1530–2PubMedCrossRef
9.
Zurück zum Zitat Liang K-Y, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986; 73: 13–22CrossRef Liang K-Y, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986; 73: 13–22CrossRef
10.
Zurück zum Zitat Neuhaus JM. Statistical methods for longitudinal and clustered designs with binary responses. Stat Methods Med Res 1992; 1: 249–73PubMedCrossRef Neuhaus JM. Statistical methods for longitudinal and clustered designs with binary responses. Stat Methods Med Res 1992; 1: 249–73PubMedCrossRef
11.
Zurück zum Zitat Huber PJ. The behaviour of maximum likelihood estimates under non-standard conditions. Proceedings of the Fifth Berkeley Symposium in Mathematical Statistics and Probability; University of California Press, 1967, 221–3 Huber PJ. The behaviour of maximum likelihood estimates under non-standard conditions. Proceedings of the Fifth Berkeley Symposium in Mathematical Statistics and Probability; University of California Press, 1967, 221–3
12.
Zurück zum Zitat White H. A heteroskedasiticity-consistent covariance matrix estimator and a direct test for heteroskedasiticity. Econometrica 1980; 48: 819–930 White H. A heteroskedasiticity-consistent covariance matrix estimator and a direct test for heteroskedasiticity. Econometrica 1980; 48: 819–930
13.
Zurück zum Zitat White H. Maximum likelihood estimation of mis-specified models. Econometrica 1982; 50: 1–25CrossRef White H. Maximum likelihood estimation of mis-specified models. Econometrica 1982; 50: 1–25CrossRef
14.
Zurück zum Zitat Efron B. Bootstrap methods: another look at the jack-knife. Ann Statist 1979; 7: 1–26CrossRef Efron B. Bootstrap methods: another look at the jack-knife. Ann Statist 1979; 7: 1–26CrossRef
15.
Zurück zum Zitat StataCorp. Stata Statistical Software. College Station (TX): Stata Corporation, 6.0, 1999 StataCorp. Stata Statistical Software. College Station (TX): Stata Corporation, 6.0, 1999
16.
Zurück zum Zitat Kriström B, Laitila T. Stated preference methods for environmental valuation: a critical look. In: Folmer H, Tietenberg T, editors. International yearbook of environmental and resource economics. Cheltenham, UK: Edgar Elgar, 2003 Kriström B, Laitila T. Stated preference methods for environmental valuation: a critical look. In: Folmer H, Tietenberg T, editors. International yearbook of environmental and resource economics. Cheltenham, UK: Edgar Elgar, 2003
Metadaten
Titel
Discrete choice experiment to derive willingness to pay for methyl aminolevulinate photodynamic therapy versus simple excision surgery in basal cell carcinoma
verfasst von
Adele Weston
Dr Patrick FitzGerald
Publikationsdatum
01.12.2004
Verlag
Springer International Publishing
Erschienen in
PharmacoEconomics / Ausgabe 18/2004
Print ISSN: 1170-7690
Elektronische ISSN: 1179-2027
DOI
https://doi.org/10.2165/00019053-200422180-00004

Weitere Artikel der Ausgabe 18/2004

PharmacoEconomics 18/2004 Zur Ausgabe

Acknowledgments

Acknowledgement